Ad Astra Diagnostics
PrivateLast Round
Accelerator
Jan 14, 2025
Total Funding Raised
$20,000
Company Overview
Ad Astra Diagnostics is a medical technology company that develops rapid point-of-care diagnostic systems for human health, including hematology analyzers for infection and sepsis detection.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ad Astra Diagnostics Comparables
Compare Ad Astra Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sight Diagnostics | 81% | |
| Soulbrain Holdings Co. Ltd | 81% | |
| Truvian | 78% | |
Ad Astra Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jan 14, 2025 | ||||
| Grant | Oct 24, 2024 |
Key People
Founding team and executive leadership
Ad Astra Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Public Health Emergency Medical Countermeasures Enterprise | Grant |
| MATTER | Accelerator |
Ad Astra Diagnostics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ad Astra Diagnostics's valuation, stock price, and market status.